Literature DB >> 3947207

Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence.

D R Weinberger, K F Berman, R F Zec.   

Abstract

To evaluate dorsolateral prefrontal cortex (DLPFC) physiology and function simultaneously, 20 medication-free patients with chronic schizophrenia and 25 normal controls underwent three separate xenon Xe 133 inhalation procedures for determination of regional cerebral blood flow (rCBF): first at rest, then while performing an automated version of the Wisconsin Card Sort (WCS), a DLPFC-specific cognitive test, and while performing a simple number-matching (NM) test. During rest, patients had significantly reduced relative, but not absolute, rCBF to DLPFC. During NM, no specific region differentiated patients from controls. During WCS, however, both absolute and relative rCBF to DLPFC significantly distinguished patients from controls. While controls showed a clear increase in DLPFC rCBF, patients did not. The changes were regionally specific, involving only DLPFC. Furthermore, in patients, DLPFC rCBF correlated positively with WCS cognitive performance, suggesting that the better DLPFC was able to function, the better patients could perform. Autonomic arousal measures, the pattern of WCS errors, and results of complementary studies suggest that the DLPFC finding is linked to regionally specific cognitive function and is not a nonspecific epiphenomenon.

Entities:  

Mesh:

Year:  1986        PMID: 3947207     DOI: 10.1001/archpsyc.1986.01800020020004

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  303 in total

1.  Subnucleus-specific loss of neurons in medial thalamus of schizophrenics.

Authors:  G J Popken; W E Bunney; S G Potkin; E G Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

2.  Effects of phencyclidine (PCP) and MK 801 on the EEGq in the prefrontal cortex of conscious rats; antagonism by clozapine, and antagonists of AMPA-, alpha(1)- and 5-HT(2A)-receptors.

Authors:  Claude Sebban; Brigitte Tesolin-Decros; Jorge Ciprian-Ollivier; Laurent Perret; Michael Spedding
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

3.  Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia.

Authors:  Frank A Middleton; Karoly Mirnics; Joseph N Pierri; David A Lewis; Pat Levitt
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

4.  The physiological role of 5-HT2A receptors in working memory.

Authors:  Graham V Williams; Srinivas G Rao; Patricia S Goldman-Rakic
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

Review 5.  Functional brain mapping of psychopathology.

Authors:  G D Honey; P C Fletcher; E T Bullmore
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-04       Impact factor: 10.154

Review 6.  Animal models of schizophrenia: a critical review.

Authors:  E R Marcotte; D M Pearson; L K Srivastava
Journal:  J Psychiatry Neurosci       Date:  2001-11       Impact factor: 6.186

7.  Coding specificity in cortical microcircuits: a multiple-electrode analysis of primate prefrontal cortex.

Authors:  C Constantinidis; M N Franowicz; P S Goldman-Rakic
Journal:  J Neurosci       Date:  2001-05-15       Impact factor: 6.167

Review 8.  The role of prefrontal cortex in working-memory capacity, executive attention, and general fluid intelligence: an individual-differences perspective.

Authors:  Michael J Kane; Randall W Engle
Journal:  Psychon Bull Rev       Date:  2002-12

Review 9.  Inhibition of the cortex using transcranial magnetic stimulation in psychiatric populations: current and future directions.

Authors:  Natasha Radhu; Lakshmi N Ravindran; Andrea J Levinson; Zafiris J Daskalakis
Journal:  J Psychiatry Neurosci       Date:  2012-11       Impact factor: 6.186

Review 10.  Cell and receptor type-specific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia.

Authors:  David A Lewis; Takanori Hashimoto; Harvey M Morris
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.